LMAT

82.91

2.75% 2.22

Handel nachbörslich: 82.91

Lemaitre Vascular Inc (LMAT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

$80.69

Offen:

$80.77

24-Stunden-Volumen:

257.86K

Relative Volume:

0.99

Marktkapitalisierung:

$1.90B

Einnahmen:

$256.28M

Nettoeinkommen (Verlust:

$62.40M

KGV:

30.55

EPS:

2.7139

Netto-Cashflow:

$79.12M

1W Leistung:

+2.37%

1M Leistung:

+2.88%

6M Leistung:

-27.67%

1J Leistung:

-3.65%

1-Tages-Spanne:

$80.03

$83.25

1-Wochen-Bereich:

$78.31

$83.25

52-Wochen-Spanne:

$78.22

$118.01

Lemaitre Vascular Inc Stock (LMAT) Company Profile

Firmenname

Lemaitre Vascular Inc

Sektor

Healthcare (1051)

Branche

Medical Instruments & Supplies (50)

Telefon

781-221-2266

Adresse

63 SECOND AVENUE, BURLINGTON, MA

Mitarbeiter

655

Twitter

@LMAT_Vascular

Nächster Verdiensttermin

2026-11-05

Neueste SEC-Einreichungen

LMAT's Discussions on Twitter

Compare LMAT vs ISRG, BDX, RMD, MDLN, ALC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LMAT Lemaitre Vascular Inc	82.91	1.90B	256.28M	62.40M	79.12M	2.7139
ISRG Intuitive Surgical Inc	427.64	151.08B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	188.89	51.45B	21.37B	1.41B	3.07B	3.9437
RMD Resmed Inc	234.60	32.99B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	35.76	31.37B	29.14B	1.07B	1.05B	1.1956
ALC Alcon Inc	64.35	31.11B	10.63B	819.00M	1.59B	1.6577

Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-08-05	Herabstufung	Barrington Research	Outperform → Mkt Perform
2025-08-06	Hochstufung	Barrington Research	Mkt Perform → Outperform
2025-02-28	Herabstufung	Barrington Research	Outperform → Mkt Perform
2025-02-28	Herabstufung	Oppenheimer	Outperform → Perform
2025-02-13	Eingeleitet	Wells Fargo	Equal Weight
2024-10-15	Eingeleitet	Cantor Fitzgerald	Neutral
2024-08-02	Fortgesetzt	Lake Street	Buy
2024-05-31	Fortgesetzt	ROTH MKM	Buy
2024-04-26	Hochstufung	Stifel	Hold → Buy
2024-02-06	Fortgesetzt	KeyBanc Capital Markets	Sector Weight
2023-10-23	Eingeleitet	JMP Securities	Mkt Outperform
2023-09-06	Eingeleitet	Oppenheimer	Outperform
2023-08-03	Herabstufung	Jefferies	Buy → Hold
2023-05-03	Hochstufung	Barrington Research	Mkt Perform → Outperform
2022-10-28	Herabstufung	Barrington Research	Outperform → Mkt Perform
2021-09-16	Eingeleitet	Jefferies	Buy
2021-02-12	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2020-03-16	Hochstufung	Sidoti	Neutral → Buy
2019-10-24	Herabstufung	First Analysis Sec	Strong Buy → Outperform
2019-10-24	Hochstufung	Lake Street	Hold → Buy
2019-10-14	Hochstufung	First Analysis Sec	Outperform → Strong Buy
2019-07-25	Bestätigt	Barrington Research	Outperform
2019-07-25	Hochstufung	First Analysis Sec	Neutral → Outperform
2018-10-08	Hochstufung	Barrington Research	Mkt Perform → Outperform
2018-10-08	Hochstufung	ROTH Capital	Neutral → Buy
2018-06-08	Fortgesetzt	ROTH Capital	Buy
2018-04-26	Herabstufung	Stifel	Buy → Hold
2018-04-26	Hochstufung	The Benchmark Company	Hold → Buy
2017-10-27	Herabstufung	First Analysis Sec	Overweight → Equal-Weight
2017-10-27	Herabstufung	The Benchmark Company	Buy → Hold
2017-07-10	Herabstufung	Canaccord Genuity	Buy → Hold
2017-07-10	Herabstufung	The Benchmark Company	Buy → Hold
2017-03-21	Eingeleitet	First Analysis Sec	Overweight
2017-02-22	Herabstufung	Barrington Research	Outperform → Mkt Perform
2016-09-22	Herabstufung	Sidoti	Buy → Neutral
2016-07-28	Bestätigt	Barrington Research	Outperform
2016-02-25	Bestätigt	Barrington Research	Outperform

Alle ansehen

Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten

Oct 12, 2026

LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026 - GlobeNewswire

Oct 12, 2026

LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026 - GlobeNewswire Inc.

Oct 12, 2026

Oct 11, 2026

LeMaitre Vascular: The Q2 Miss Hides A Stronger Acquisition Machine (NASDAQ:LMAT) - Seeking Alpha

Oct 01, 2026

Sep 30, 2026